欧美日本一道本一区二区_亚洲免费影视_91手机在线看片_精品欧美成人高清在线观看_少妇作爱bbbb免费看_51久久夜色精品国产水果派解说

美國GeneGo?
GeneGo是為系統生物學中的數據挖掘應用提供領先的化學信息學和生物信息學軟件解決方案的供應商。公司的產品為從基因組學和代謝組學到蛋白質組學和毒理基因組學的研 究與實驗提供支持。MetaBase是GeneGo專業研制的哺乳動物生物學與藥物化學數據庫，是目前在系統生物學領域覆蓋范圍最廣的數據庫。 MetaCore是公司的旗艦產品，為系統生物學研究中的通路分析和生物標記物發現提供了完整的數據挖掘工具套件。

MetaDrug是GeneGo的系統藥理學平臺，在結合化學信息學和生物信息學基礎上，該平臺為轉化醫學、免疫學、炎癥與腫瘤研究提供了有力的預測工具。GeneGo產 品的客戶以知名大學和大型生命科學公司為主，他們遍及歐洲、亞洲和美國。通過與來自業界與學術界的研究者的廣泛合作，GeneGo致力于推動生物信息學軟件的應用，為加快發現新療法與生物標記物提供強力支持。

GeneGo的工具和數據庫能夠幫助研究人員挖掘和定義各種高通量實驗數據背后潛在的生物學意義，了解小分子藥物在人體組織中的作用。GeneGo公司還為生命科學研究和藥物開發的不同應用范圍提供了全方位的解決方案，包括從臨床前的疾病發現到臨床治療中的NCE應用，其范圍涵蓋了生物學與化學的所有方面。
?

GeneGo is a leading provider of data mining & analysis solutions in systems biology. Our data mining tools and databases help to capture and define the underlying biology behind different types of high-throughput experimental data and understand the effects of small molecule drug compounds in human tissues. We provide systems biology solutions for a full range of applications in life science research and drug development, from pre-clinical discovery and NCE applications to clinical trials, covering all aspects of biology and chemistry.

?

GeneGo’s flagship bioinformatics product in systems biology, MetaCore?, assists scientists in three main areas:

Drug target selection and validation;
Identification of biomarkers for specific disease states and
Patient profiling in clinical trials.
Whether the data derives from microarray gene expression studies, SNPs, metabolic profiles or high content screening (HCS) assays, MetaCore’s sophisticated analytical data mining tools enable the identification and prioritization of the most relevant pathways, networks and cellular processes affected by the condition. The MetaCore? suite works on the proprietary content of MetaBase?, GeneGo’s manually curated database of mammalian biology and medicinal chemistry. MetaBase? is the most comprehensive knowledge base available today in systems biology. It allows scientists to network virtually all known human signaling and metabolic reactions and to understand how bioactive compounds interact with and affect these networks based on experimental data. Our second product, MetaDrug?, is GeneGo’s fully assembled systems pharmacology platform that can be used to predict human metabolites, toxicity and mode of action of novel small molecule compounds.

GeneGo’s customer list for our systems biology product offerings includes the largest life science companies and leading universities and research institutions in the US, Europe and Asia. We partner with a broad group of investigators in academy and industry with matching data analysis technologies, content databases and data analysis projects.

Tatiana Nikolskaya, Ph.D., previously a molecular biologist at the University of Chicago, founded GeneGo in 2000. Based on her extensive wet lab background, Dr. Nikolskaya defined the immediate utility of GeneGo technology for bench researchers as the key objective. The GeneGo multi-disciplinary team includes experts in molecular and systems biology, metabolism, graph theory, human diseases and medicinal chemistry. The company employs over 90 scientists and software developers at the corporate headquarters in St. Joseph, MI, with offices in San Diego, CA and in Moscow, Russia. GeneGo is a private company owned by the management team. Its sales revenues and technology grants fund ongoing research and product development for bioinformatics applications within systems biology.

?